Difference between revisions of "Talk:ELOC-mutated renal cell carcinoma"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931622/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931622/ | ||
cyclin D1, beta-catenin ??? | cyclin D1, beta-catenin ??? | ||
https://pubmed.ncbi.nlm.nih.gov/31748879/ | https://pubmed.ncbi.nlm.nih.gov/31748879/ | ||
cyclin D1 +ve subset of ccRCC has favourable prognosis | cyclin D1 +ve subset of ccRCC has favourable prognosis | ||
https://pubmed.ncbi.nlm.nih.gov/35653922/ | |||
Revision as of 16:20, 6 March 2025
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931622/ cyclin D1, beta-catenin ???
https://pubmed.ncbi.nlm.nih.gov/31748879/ cyclin D1 +ve subset of ccRCC has favourable prognosis